Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
Choice, Implementation Intentions and Colorectal Cancer Screening
1 other identifier
interventional
600
1 country
1
Brief Summary
The goal of this study is to improve use of colorectal cancer screening among screening eligible African Americans who are served by Federally Qualified Health Centers in Michigan. The main questions it aims to answer are:
- To what extent to individual prefer and select to complete screening with colonoscopy versus stool-based (FIT Kit or sDNA) options?
- Can full completion of (i.e. follow-through with) screening with a selected modality be enhanced by delivery of a culturally targeted intervention? Participants will learn about colonoscopy, FIT Kit and sDNA as recommended and widely used screening options. Participants will select a modality to complete their own screening with. Participants will then be randomized to one of three arms (usual care, standard intervention, culturally targeted intervention). Researchers will compare the extent to which intervention arms enhance completion rates across each of the three screening modalities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started Jul 2023
Typical duration for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2023
CompletedFirst Submitted
Initial submission to the registry
October 10, 2023
CompletedFirst Posted
Study publicly available on registry
October 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
September 16, 2025
September 1, 2025
3 years
October 10, 2023
September 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Colorectal Cancer Screening Modality Request Rates
Frequency (percentage) with which colonoscopy versus FIT Kit versus sDNA kit versus no screening are selected.
up to 2 weeks
Colorectal Cancer Screening Completion Rate
Frequency (percentage of time) that chosen screening method is fully completed.
up to 6 months
Theory of Planned Behavior Colorectal Cancer Screening Outcomes
Self-report measures of colorectal cancer screening attitudes, norms, perceived control, intentions to be screened are each adapted from published research (Lucas et al., 2021). These items are constructed following recommended procedures to ensure construct validity and adequate behavioral specificity (Fishbein \& Ajzen, 2011). All items use Likert-type scales that range from 1 (strongly agree) to 7 (strongly disagree).
collected immediately, up to 1 hour
Anticipatory Racism
Adapted from published research (Lucas et al., 2021), all participants respond to questions that asked whether they believe racism would impact the benefits they could experience from obtaining colorectal cancer screening. Participants will then respond to three questions that ask, "In some way, my obtaining CRC screening would be impacted by racism," "Racism would undermine the value of CRC screening for me." and "Racism would negatively impact the accuracy of my CRC screening. Responses are collected using a 7-point Likert-type scale that ranged from 1 (strongly agree) to 7 (strongly disagree).
collected immediately, up to 1 hour
Study Arms (3)
Usual Care Message
ACTIVE COMPARATORParticipants selecting a colorectal cancer screening will receive "usual care" from the FQHC.
Implementation Intention Intervention: Standard Message
ACTIVE COMPARATORParticipants selecting a colorectal cancer screening will receive implementation intention messages in addition to the "usual care" from the FQHC.
Implementation Intention Intervention: Culturally-Targeted Message
EXPERIMENTALParticipants selecting a colorectal cancer screening will receive culturally-targeted implementation intention messages in addition to the "usual care" from the FQHC.
Interventions
Usual care is provided by the FQHC for the screening option chosen.
Implementation Intention Intervention module includes standard messaging in addition to the usual care provided by the FQHC for the screening option chosen.
Implementation Intention Intervention module includes culturally-targeted framing of health information messages in addition to the usual care provided by the FQHC for the screening option chosen.
Eligibility Criteria
You may qualify if:
- African American, ages 45-72, Medicaid or Medicare insurance, enrolled in a FQHC, eligible for CRC screening (Colonoscopy more than 10 years ago, Sigmoidoscopy more than 5 years ago, FOB test more than 1 year ago, FIT kit more than 1 year ago, sDNA test more than 3 years ago, Never been screened).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Michigan State Universitylead
- American Cancer Society, Inc.collaborator
Study Sites (1)
Michigan State University
Flint, Michigan, 48502, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be unaware of their assignment to usual care vs. intervention conditions
- Purpose
- SCREENING
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- C.S. Mott Endowed Professor
Study Record Dates
First Submitted
October 10, 2023
First Posted
October 17, 2023
Study Start
July 12, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
September 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Upon Study Completion
Data will be made available per requirements and sharing structures established by the American Cancer Society.